Comprehensive and Validated Chromatographic Techniques for the Estimation of Lercanidipine Hydrochloride and Atenolol in Bulk and Combined Dosage Form in the Presence of Lercanidipine Degradation Products with LC/MS Characterization
Journal of Chromatographic Science · 2024
DOI: 10.1093/chromsci/bmad018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chromatographic Science, 2024. Verfasst von Shereen A Boltia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., P.O. Box 11562, Cairo, Egypt. Hauptthemen laut MEDLINE: Atenolol, Dihydropyridines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Two rapid, smart and validated stability indicating HPLC and TLC techniques were developed to determine atenolol (ATE) and lercanidipine HCl (LER) simultaneously in their pharmaceutical formulation. HPLC chromatographic separation was implemented by using Microsorb C18 (250 × 4.6 mm, 5 μm) column, with mobile phase of acetonitrile and 20 mM potassium dihydrogen phosphate buffer pH 3.5 adjusted by orthophosphoric acid in the ratio of (65:35, v/v) at a flow rate of 1.2 mL/min at 240 nm also the injection volume adjusted to be 30 μL. These selected conditions effectively separated ATE and LER at a retention time of 2 and 6.7 min, respectively, by isocratic elution mode without any interference from the obtained degradation products of LER. The densitometric determination was performed by using precoated silica gel 60F254 aluminum plates and chloroform, methanol and triethylamine (11.3:1.3: 0.3, by volume) as a developing system. The detection wavelength for simultaneous estimation of both drugs was 240 nm in the presence of the oxidative product of LER. The RF values for ATE and LER were 0.22 and 0.78, respectively. The calibration curves of both techniques were constructed with linearity ranges of (5–55) μg.mL−1 and (1–55) μg.mL−1 for both ATE and LER, respectively, for HPLC determination. While for TLC, the linearity ranges were (1–4) μg/band and (0.2–1.4) μg/band for ATE and LER, respectively. LER degradation products were characterized using UPLC/MS and the suggested mechanisms and degradation pathways were introduced.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., P.O. Box 11562, Cairo, Egypt.
- Pharmaceutical Chemistry Department, National Organization for Drug Control and Research (NODCAR), Aguza, Giza, Egypt.
ORCID-Profile: Marwa T Saad
Zitieren
APA
Boltia, S. A., Fattah, T. A., Saad, M. T., & Zaazaa, H. E. (2024). Comprehensive and Validated Chromatographic Techniques for the Estimation of Lercanidipine Hydrochloride and Atenolol in Bulk and Combined Dosage Form in the Presence of Lercanidipine Degradation Products with LC/MS Characterization. Journal of Chromatographic Science. https://doi.org/10.1093/chromsci/bmad018
Vancouver
Boltia SA, Fattah TA, Saad MT, Zaazaa HE. Comprehensive and Validated Chromatographic Techniques for the Estimation of Lercanidipine Hydrochloride and Atenolol in Bulk and Combined Dosage Form in the Presence of Lercanidipine Degradation Products with LC/MS Characterization. Journal of Chromatographic Science. 2024. doi:10.1093/chromsci/bmad018
BibTeX
@article{Boltia2024,
author = {Boltia, Shereen A and Fattah, Taghreed A and Saad, Marwa T and Zaazaa, Hala E},
title = {Comprehensive and Validated Chromatographic Techniques for the Estimation of Lercanidipine Hydrochloride and Atenolol in Bulk and Combined Dosage Form in the Presence of Lercanidipine Degradation Products with LC/MS Characterization},
journal = {Journal of Chromatographic Science},
year = {2024},
doi = {10.1093/chromsci/bmad018}
}
EUVIMED